Oral Iron Chelators for the Clinical Management of Iron Overload
Author:
- 17 December 1990
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 612 (1) , 311-314
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Closing RemarksAnnals of the New York Academy of Sciences, 1990
- Chelation Therapy and Cardiac Status in Older Patients with Thalassemia MajorJournal of Pediatric Hematology/Oncology, 1990
- SAFETY OF ORAL IRON CHELATOR L1The Lancet, 1989
- AGRANULOCYTOSIS AND THROMBOCYTOPENIA IN PATIENT WITH BLACKFAN-DIAMOND ANAEMIA DURING ORAL CHELATOR TRIALThe Lancet, 1989
- ANIMAL TOXICOLOGY OF IRON CHELATOR L1The Lancet, 1989
- Oral iron chelating drugs: coming but not yet ready for clinical useBMJ, 1988
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976
- PREVENTION OF BONE MALFORMATIONS AND CARDIOMEGALY IN COOLEY'S ANEMIA BY EARLY HYPERTRANSFUSION REGIMEN*Annals of the New York Academy of Sciences, 1969
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964